Benitec Biopharma Limited
BNTCW
BNTCW was delisted on the 14th of April, 2020.
3 hedge funds and large institutions have $15K invested in Benitec Biopharma Limited in 2016 Q4 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$9.9K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.04K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$28 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $10K | +$9.9K | +98,146 | New |
|
|
2
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $5K | +$5.04K | +50,000 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| – | +$28 | +279 | New |
|
BNTCW Hedge Fund Activity: Q4 2016 in Review
3 of the 4,001 institutional investors tracked by Wall St. Rank reported a position in Benitec Biopharma Limited (BNTCW) for Q4 2016, worth a combined $15K.
Buyers outnumbered sellers: 3 funds opened new BNTCW positions and 0 closed out — a net gain of 3 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $9.9K.
- 3 institutional investors held Benitec Biopharma Limited (BNTCW) as of Q4 2016, up from 0 in Q3 2016.
- Funds reported $15K of Benitec Biopharma Limited stock for Q4 2016.
- 3 funds opened new Benitec Biopharma Limited positions in Q4 2016 and 0 closed out, a net change of +3 holders.
- The largest Benitec Biopharma Limited buyer in Q4 2016 was Sabby Management, an estimated $9.9K added.
Based on aggregated 13F filings for Q4 2016.